Early Phase 1 Autism Spectrum Disorder Trial, Recruiting NCT07432776 Sponsor: Penn State University Condition: Autism Spectrum Disorder
Back to Autism Spectrum Disorder

Early Phase 1 Autism Spectrum Disorder Trial, Recruiting

NCT07432776
Recruiting Early Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between 18 and 45 years old
  • People who have been clinically diagnosed with autism spectrum disorder (ASD)
  • People who are able to take part in group activities without needing a carer or support person present
  • People who can understand English and communicate independently, without assistance
  • People who are available to attend at least two sessions per week during the intervention period
  • People who have reliable transport to get to the location where the trial takes place
  • People who are able to give their own informed consent to participate, without needing a legal representative to do so on their behalf
  • People whose pre-exercise health screening shows that a doctor's medical clearance is not required before exercising, based on standard guidelines (confirm with trial site)

Who may not be able to join:

  • People who have a clinical diagnosis of intellectual disability
  • People who do not have normal vision or vision that is fully corrected (for example, with glasses or contact lenses)
  • People who are already playing a racquet sport (such as tennis, badminton, or squash) at least once a week
  • People who use mobility aids (such as a wheelchair, walker, or crutches)
  • People who experience moderate to severe joint pain, as measured by a standard assessment tool (confirm with trial site)
  • People who have certain neurological conditions, including cerebral palsy, severe head injury, progressive neurological disorders, or epilepsy
  • People who require a legal representative to provide consent on their behalf
  • People whose pre-exercise health screening indicates that a doctor's medical clearance is needed before they can exercise safely, based on standard guidelines (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Early Phase 1
Sponsor
Penn State University
Registry
ClinicalTrials.gov
Start date
2 February 2026
Est. completion
15 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Sensory-Motor Function (HaptiKart task outcomes); Autism Symptom Severity (SRS-2 Total Score)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov